| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |